GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Regeneron Pharmaceuticals REGN · USD

Health Care · Biotechnology · US listing · 🇺🇸 United States

S&P 500Nasdaq-100

Compare

919.96

+1.73%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Regeneron Pharmaceuticals

Our reporting

Next results

28 Jan 2027

Due on 28 Jan 2027. Analysts expect earnings of 25.30 a share on revenue of $5.85bn.

Past results

Reported against what analysts expected

30 Oct 202630 Jul 202629 Apr 202630 Jan 202628 Oct 20251 Aug 2025
Earnings per share20.0714.299.4711.4411.8312.89
Forecast16.5110.168.9110.749.658.43
Revenue$5.12bn$4.29bn$3.61bn$3.88bn$3.75bn$3.68bn
Forecast$4.58bn$3.82bn$3.48bn$3.81bn$3.59bn$3.29bn

Key events

  1. 1 Jan 1991Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.